Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Predictive Oncology Inc (NASDAQ: POAI) closed at $1.50 in the last session, down -23.08% from day before closing price of $1.95. In other words, the price has decreased by -$23.08 from its previous closing price. On the day, 1.16 million shares were traded.
Ratios:
We take a closer look at POAI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 1.22 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 19, 2024, initiated with a Buy rating and assigned the stock a target price of $3.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.25 while its Price-to-Book (P/B) ratio in mrq is 5.09.
Stock Price History:
Over the past 52 weeks, POAI has reached a high of $3.76, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is 25.22%, while the 200-Day Moving Average is calculated to be 39.65%.
Shares Statistics:
A total of 6.67M shares are outstanding, with a floating share count of 6.56M. Insiders hold about 1.59% of the company’s shares, while institutions hold 3.61% stake in the company.
